0000950157-19-001374.txt : 20191129 0000950157-19-001374.hdr.sgml : 20191129 20191129162320 ACCESSION NUMBER: 0000950157-19-001374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191126 FILED AS OF DATE: 20191129 DATE AS OF CHANGE: 20191129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mooberry Derik CENTRAL INDEX KEY: 0001533186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11693 FILM NUMBER: 191261415 MAIL ADDRESS: STREET 1: C/O SCIENTIFIC GAMES CORPORATION STREET 2: 6601 BERMUDA ROAD CITY: LAS VEGAS STATE: NV ZIP: 89119 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCIENTIFIC GAMES CORP CENTRAL INDEX KEY: 0000750004 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] IRS NUMBER: 810422894 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6601 BERMUDA ROAD CITY: LAS VEGAS STATE: NV ZIP: 89119 BUSINESS PHONE: 7028977150 MAIL ADDRESS: STREET 1: 6601 BERMUDA ROAD CITY: LAS VEGAS STATE: NV ZIP: 89119 FORMER COMPANY: FORMER CONFORMED NAME: AUTOTOTE CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: UNITED TOTE INC DATE OF NAME CHANGE: 19920317 4 1 form4.xml X0306 4 2019-11-26 0000750004 SCIENTIFIC GAMES CORP SGMS 0001533186 Mooberry Derik C/O SCIENTIFIC GAMES CORPORATION 6601 BERMUDA ROAD LAS VEGAS NV 89119 true EVP & Grp Chief Exec, Gaming Common Stock 2019-11-26 4 M 0 7523 12.83 A 21939 D Common Stock 2019-11-26 4 M 0 7299 9.65 A 29238 D Common Stock 2019-11-26 4 M 0 7648 9.65 A 36886 D Common Stock 2019-11-26 4 M 0 5242 21.6 A 42128 D Common Stock 2019-11-26 4 M 0 5242 21.6 A 47370 D Common Stock 2019-11-26 4 S 0 32954 28.19 D 14416 D Common Stock 2019-11-27 4 M 0 1388 12.83 A 15804 D Common Stock 2019-11-27 4 M 0 4441 9.65 A 20245 D Common Stock 2019-11-27 4 M 0 4092 9.65 A 24337 D Common Stock 2019-11-27 4 S 0 9921 27.15 D 14416 D Employee Stock Option (right to buy) 12.83 2019-11-26 4 M 0 7523 12.83 D 2025-04-26 Common Stock 7523 1388 D Employee Stock Option (right to buy) 9.65 2019-11-26 4 M 0 7299 9.65 D 2026-06-20 Common Stock 7299 16181 D Employee Stock Option (right to buy) 9.65 2019-11-26 4 M 0 7648 9.65 D 2026-06-20 Common Stock 7648 15832 D Employee Stock Option (right to buy) 21.6 2019-11-26 4 M 0 5242 21.6 D 2027-03-08 Common Stock 5242 10483 D Employee Stock Option (right to buy) 21.6 2019-11-26 4 M 0 5242 21.6 D 2027-03-08 Common Stock 5242 10483 D Employee Stock Option (right to buy) 12.83 2019-11-27 4 M 0 1388 12.83 D 2025-04-26 Common Stock 1388 0 D Employee Stock Option (right to buy) 9.65 2019-11-27 4 M 0 4441 9.65 D 2026-06-20 Common Stock 4441 11740 D Employee Stock Option (right to buy) 9.65 2019-11-27 4 M 0 4092 9.65 D 2026-06-20 Common Stock 4092 11740 D The stock option transactions herein were executed by Mr. Mooberry in order to diversify his portfolio. These transactions did not affect Mr. Mooberry's ownership of actual shares of the Company's common stock, which was 14,416 shares of common stock both before and after these transactions. The transaction was executed in multiple trades at prices ranging from $28.00 to $28.77. The price reported above reflects the weighted average sale price. Details regarding aggregated sales transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. The transaction was executed in multiple trades at prices ranging from $26.67 to $27.34. The price reported above reflects the weighted average sale price. Details regarding aggregated sales transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer. The options became exercisable on April 27, 2019. The options became exercisable as to 11,740 shares on March 20, 2019 and will become exercisable as to the remaining 11,740 shares on March 20, 2020. Vesting of these options was contingent on the Company's common stock attaining a defined stock price hurdle on or before March 20, 2020. The stock price hurdle was achieved on February 2, 2017. The options became exercisable as to 11,740 shares on March 20, 2019 and will become exercisable as to the remaining 11,740 shares on March 20, 2020. The options became exercisable as to 5,242 shares on March 20, 2019 and will become exercisable as to the remaining shares on each of March 20, 2020 (5,241 shares) and March 20, 2021 (5,242 shares). Vesting of these options was contingent on the Company's common stock attaining a defined stock price hurdle on or before March 20, 2021. The stock price hurdle was achieved on August 11, 2017. The options became exercisable as to 5,242 shares on March 20, 2019 and will become exercisable as to the remaining shares on each of March 20, 2020 (5,241 shares) and March 20, 2021 (5,242 shares). /s/ Melissa Bengtson, attorney-in-fact for Derik Mooberry 2019-11-29